Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma
Clinical trial NCT03922880 · COMPLETED
Trial details
- NCT number
- NCT03922880
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-16
- Primary completion
- 2023-01-20
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.